Craft

3DBiopsy

Total Funding

$2.2 M

3DBiopsy Summary

Company Summary

Overview
3DBiopsy is a company developing a system for diagnosis and treatment planning of prostate cancer. It provides the image-guided software designed to create a transperineal biopsy plan, the integrated pathology system (IPS) to receive unfragmented specimens, and the TRUS biopsy device to receive a tissue sample.
Type
Private
Status
Active
Founded
2012
Website
https://www.triopsy.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Brad J. Buscher

    Brad J. Buscher, Executive Chairman of the Board

  • David G. Bostwick

    David G. Bostwick, Chief Executive Officer

    • Paul Arangua

      Paul Arangua, Director of Research and Product Development

    Footer menu